Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD62L specific lentiviral vector particle for targeted transduction of T cell subsets

CD62L specific lentiviral vector particle for targeted transduction of T cell subsets

US Patent 12018273 · Granted Jun 25, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Adapter-based retroviral vector system for the selective transduction of target 2025
Adapter-based retroviral vector system for the selective transduction of target 2025
Reducing side effects of immunotherapy using genetically modified hematopoietic 2025
LDLR negative packaging cell line for the production of VSV-G pseudotyped retrov2025
Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hemat2025
Regulatory T cell expressing a chimeric antigen receptor2024
Immune cells expressing an antigen binding receptor and a chimeric costimulatory2024
Combination of immune effector cells specific for a target antigen and hematopoi2024
Nipah virus envelope glycoprotein pseudotyped lentivirus2023
Immunotherapy method comprising administering a combination of immune effector c2022
Combination of immune effector cells specific for a target antigen and hematopoi2021
Pseudotyping of retroviral vectors, methods for production and use thereof for t2019